MAX - SHOCK Clinical Trial

NCT06556667 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

376

Enrollment

OTHER

Sponsor class

Conditions

Cardioversion
Atrial Fibrillation

Interventions

DEVICE: biphasic defibrillator with maximum energy of 200J (® Zoll)
DEVICE: biphasic defibrillator with maximum energy of 360J (® Physio-Control)

Sponsor

Ottawa Heart Institute Research Corporation